Need Lobbying Data?
Get in touch to learn more about our lobbying database, request data samples, and start a trial.
Menu
Lobbying Data updated every 24 hours.
Extract value from the $3.73 billion lobbying industry using our intelligently crafted, easy to understand data design.
| Full Lobbying Report Link | Who Lobbied? | Is the Client a Govt. Entity? | Lobbying Firm Retained | Lobbyist(s) Hired | General Issues Lobbied On | Specific Issues Lobbied On | Govt. Agencies Lobbied | Dollar Amount Spent | Filing Type | Date Posted |
|---|---|---|---|---|---|---|---|---|---|---|
| View Report | The Independence Fund | No | Two Branch Strategies | Raymond Kelley | Veterans | Staying in touch with house committee on veterans affairs staff and tracking which bills are moving through committee. S. 141 | House of Representatives, Senate | 30,000 | 4th Quarter - Report | 12/24/2024 |
| View Report | Our Children's Trust | No | Our Children's Trust | Elizabeth Lee | Civil Rights/Civil Liberties, Clean Air and Water (quality), Constitution, Energy/Nuclear, Environment/Superfund, Fuel/Gas/Oil, Natural Resources | Recognition of the constitutional rights of children to a life-sustaining climate, life, liberty, personal security, public trust resources, and equal protection of the law, informed by the best science of climate stabilization and Earth Energy Balance (350 ppm CO2); Children's Fundamental Rights and Climate Recovery Resolution on recognizing the climate crisis is disproportionately affecting the health, economic opportunity, and fundamental rights of children; potential forthcoming resolution on children's constitutional rights to equal protection, to life and a life-sustaining climate.  | House of Representatives, Senate | 4th Quarter - Report | 12/24/2024 | |
| View Report | Avac (aids Vaccine And Advocacy Coalition) | No | Collier Collective, Llc | Jenny Collier | Budget/Appropriations | Advocate for inclusion of funding and report language to resource and direct CDC to develop and support a national PrEP program to provide PrEP (HIV prevention medication) to people in need nationwide in the FY25 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bills. | CDC, House of Representatives, Senate | 3rd Quarter - Report | 12/24/2024 | |
| View Report | Avac (aids Vaccine And Advocacy Coalition) | No | Collier Collective, Llc | Jenny Collier | Budget/Appropriations | Advocate for inclusion of funding and report language to resource and direct CDC to develop and support a national PrEP program to provide PrEP (HIV prevention medication) to people in need nationwide in the FY25 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bills. | CDC, House of Representatives, Senate | 40,000 | 2nd Quarter - Report | 12/24/2024 |
| View Report | Avac (aids Vaccine And Advocacy Coalition) | No | Collier Collective, Llc | Jenny Collier | Budget/Appropriations | Advocate for inclusion of funding and report language to resource and direct CDC to develop and support a national PrEP program to provide PrEP (HIV prevention medication) to people in need nationwide in the final FY24 and in the FY25 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bills. | CDC, House of Representatives, Senate | 40,000 | 1st Quarter - Report | 12/24/2024 |
| View Report | Youth Advocate Programs, Inc. | No | Collier Collective, Llc | Jenny Collier | Budget/Appropriations, Law Enforcement/Crime/Criminal Justice | FY25 funding in the Commerce, Justice, Science and Related Agencies appropriations bill for youth justice programs at the Office of Juvenile Justice and Delinquency Prevention at the Department of Justice as well as Community Violence Intervention programs at the Department of Justice., Reauthorization of the Juvenile Justice and Delinquency Prevention Act. | House of Representatives, Senate, office of Juvenile Justice & Delinquency Prevention | 40,000 | 3rd Quarter - Report | 12/24/2024 |
| View Report | Justice Strikeforce | No | Collier Collective, Llc | Danielle Neal, Jenny Collier | Law Enforcement/Crime/Criminal Justice | Advocated for expanding federal support for victims/survivors of crime. | DOJ, House of Representatives, Senate, office of Justice Program | 20,000 | 3rd Quarter - Report | 12/24/2024 |
| View Report | Pearl Mobile Dtv Company Llc | No | Cogent Strategies Llc | 4th Quarter - Termination (No Activity) | 12/26/2024 | |||||
| View Report | The Coalition For Renewable Natural Gas | No | Cogent Strategies Llc | Andrew Kauders, Claudia James, Randall Gerard, Taylor Hoover | Energy/Nuclear, Taxation/Internal Revenue Code | - Implementation of HR 5376, Inflation Reduction Act of 2022, - Issues related to the US renewable natural gas industry | House of Representatives, Senate | 30,000 | 4th Quarter - Termination | 12/26/2024 |
| View Report | Aoac International | No | Auburn Health Strategies, Llc | 4th Quarter - Report (No Activity) | 12/26/2024 | |||||
| View Report | American Proficiency Institute | No | Auburn Health Strategies, Llc | Robin Stombler | Medical/Disease Research/Clinical Labs | proficiency testing for clinical laboratories | HHS | 4th Quarter - Report | 12/26/2024 | |
| View Report | Invest In Education Coalition | No | 2020 Strategies Llc | John Schilling | Education | Educational Choice for Children Act | House of Representatives, Senate | 18,000 | 4th Quarter - Termination | 12/26/2024 |
| View Report | Dfi Action | No | 2020 Strategies Llc | John Schilling | Education | SOAR Act, DC Opportunity Scholarship Program Federal school choice legislation | House of Representatives, Senate | 15,000 | 4th Quarter - Report | 12/26/2024 |
| View Report | Medtronic Inc. | No | Government Counsel, Llc | 30,000 | 4th Quarter - Termination (No Activity) | 12/28/2024 | ||||
| View Report | Baycare Health System | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for Medicare, Medicaid and Marketplace coverage. H.R. 8260 - Hospital Inpatient Services Modernization Act of 2024 - Support for the extension of the Hospital at Home waiver program. H. R. 7742 - The At HOME Services Act - Support for the current Medicare and Medicaid Hospital at Home programs and the addition of a pilot to support observation level patients at home. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023. Support for policies to provide more affordable and accessible health plans. H.R. 5378 - Lower Costs, More Transparency Act - Issues related to the treatment of 340b and qualified hospitals that serve vulnerable populations. H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to the continued coverage of telemedicine benefit to increase the reach of coverage for underserved communities. Issues related to the implementation of the CMS Hospital at Home waiver, which was continued by the passage of the Consolidated Appropriations Act for FY 2023. Rules, Regulations and Guidance related to hospitals under the annual prospective payment rules. Issues related to Medicare and Medicaid DSH Issues related to developing innovative models of care under the Medicare program. Issues related to mental and behavioral health care and increasing access to and workforce for patients., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for Medicare, Medicaid and Marketplace programs, 340b and other programs vital for not-for-profit hospitals. H.R. 8260 - Hospital Inpatient Services Modernization Act of 2024 - Support for the extension of the Hospital at Home waiver program. H. R. 7742 - The At HOME Services Act - Support for the current Medicare and Medicaid Hospital at Home programs and the addition of a pilot to support observation level patients at home. S. 3393 - Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment Reauthorization Act - Support for continuing the national priority to help individuals and families impacted by substance use. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023. Support for policies to provide more affordable and accessible health plans. H.R. 5378 - Lower Costs, More Transparency Act - Issues related to the treatment of 340b and qualified hospitals that serve vulnerable populations. H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to the continued coverage of telemedicine benefit to increase the reach of coverage for underserved communities. Issues related to 340b qualified hospitals and ensuring that they are able to best serve vulnerable patients and populations. Issues related to the implementation of the CMS Hospital at Home waiver, which was continued by the passage of the Consolidated Appropriations Act for FY 2023. Rules, Regulations and Guidance related to hospitals under the annual prospective payment rules. Issues related to Medicare and Medicaid DSH Issues related to developing innovative models of care under the Medicare program. Issues related to social determinants of health with an emphasis on food as medicine and other anti-hunger and pro-nutrition initiatives. Issues related to mental and behavioral health care and increasing access to and workforce for patients. | CMS, House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Quest Diagnostics Incorporated | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for health care programs and support for a delay to certain cuts to laboratory payments covered by Medicare. Rules and regulations related to FDA's treatment of certain laboratory developed tests. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues. Issues related to testing for STDs. Issues related to testing for PFAS. Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for health care programs and support for a delay to certain cuts to laboratory payments covered by Medicare. Issues related to combatting the syphilis crisis in the United States and its impact on underserved communities. H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. | House of Representatives, Senate | 80,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | The Guardian Life Insurance Company Of America | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on health insurance products. H.R. 1617 - Access to Dental Insurance Act of 2023 - Support for allowing certain populations to receive dental coverage through the federal insurance marketplaces. Issues related to the inclusion in the Inflation Reduction Act, and continued implementation of the enhanced APTCs in the health care marketplace to make coverage more affordable. Issues related to ensuring that Medicaid and Marketplace coverage includes quality dental insurance., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. S. 3680 - Paid Family and Medical Leave Tax Credit Extension and Enhancement Act - Support for innovative models to support PFML in the United States. H.R. 1617 - Access to Dental Insurance Act of 2023 - Support for allowing certain populations to receive dental coverage through the federal insurance marketplaces. Issues related to paid family medical leave. Issues related to the inclusion in the Inflation Reduction Act, and continued implementation of the enhanced APTCs in the health care marketplace to make coverage more affordable. Issues related to ensuring that Medicaid and Marketplace coverage includes quality dental insurance. | House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Boston Medical Center | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 Issues related to funding government departments and agencies responsible for administering programs that support Medicaid, Medicare and Marketplace health care coverage. HHS Rules and Regulations focused on the promulgation of the 340b program. S.3565/H.R. 6962 - The Affordable Connectivity Program Extension Act - Support for the extension of the covid-era program to ensure low income patients have accesses to vital connectivity to support their health care at home. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the extension of the covid-era program to support patients at home. S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports H.R. 5378 - Lower Cost, More Transparency Act of 2023 - Issues related to hospital transparency, the importance of the 340b to hospitals caring for low-income, vulnerable patients and the importance of hospital community benefit programs. H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to continued and expanded coverage. HHS Rules, Regulations and Guidance regarding maternal health, social determinants of health and other issues driving greater access and equity in the health care system. HHS Rules, Regulations and Guidance regarding Medicaid Reentry programs covering incarcerated individuals returning to society. Issues related to commitments to health care's commitment environmental health. Issues related to food security and nutrition as part of health care. Issues related to Medicaid DSH, 340b and other programs that help support safety net hospitals to best support care for vulnerable populations., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the extension of the covid-era program to support patients at home. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Strong support for needed tools to support access to affordable health care and continuation of vital hospital supports, like Medicaid DSH. H.R. 5378 - Lower Cost, More Transparency Act of 2023 - Issues related to hospital transparency, the importance of the 340b to hospitals caring for low-income, vulnerable patients and the importance of hospital community benefit programs. Support for the expansion of Medicaid DSH, Community Health Centers and other safety net programs reauthorized in the measure. H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to continued and expanded coverage. HHS Rules, Regulations and Guidance regarding maternal health, social determinants of health and other issues driving greater access and equity in the health care system. HHS Rules, Regulations and Guidance regarding Medicaid Reentry programs covering incarcerated individuals returning to society. Issues related to Medicaid DSH, 340b and other programs that help support safety net hospitals to best support care for vulnerable populations. | CMS, House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Carefirst Bluecross Blueshield | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on the promulgation of Medicare Advantage and Medicare Part D. H.R 7623 - Telehealth Modernization Act of 2024 - Support for extension of Covid-era telemedicine provisions. Support for extension of ACA APTCs to support affordable coverage in the SBM and FFM insurance marketplaces. Issues related to models developed by the Center for Medicare and Medicaid Innovation. H.R. 7024 - Tax Relief for American Families and Workers Act of 2024 - Issues related to the expansion of the child tax credit and other tax provisions. S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports. Rules and regulations related to lowering the cost of prescription medications and the implementation of the Inflation Reduction Act. Issues related to identifying and addressing social determinants of health. Issues related to the insurance Marketplace and providing full and affordable coverage options. | House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Blue Cross Blue Shield Of Massachusetts | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Wage Index. Issues related to Medicare Advantage stars and other quality ratings. H.R 7623 - Telehealth Modernization Act of 2024 - Support for extension of Covid-era telemedicine provisions. Support for extension of ACA APTCs to support affordable coverage in the SBM and FFM insurance marketplaces. H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies. H.R. 7024 - Tax Relief for American Families and Workers Act of 2024. - Support for the expansion of the current child tax credit and other policies. S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports Issues related to making over-the-counter Naloxone accessible and available. Issues related to improving mental health care access for plan members and Medicare beneficiaries. Rules, Regulations and legislative policies related to the Medicare Advantage program. Issues related to identifying and addressing social determinants of health. Issues related to the insurance Marketplace and providing full and affordable coverage options., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Wage Index. H.R 7623 - Telehealth Modernization Act of 2024 - Support for extension of Covid-era telemedicine provisions. Support for extension of ACA APTCs to support affordable coverage in the SBM and FFM insurance marketplaces. H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access in the Medicare, Medicaid and Marketplaces. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies. S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use. S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports Issues related to improving mental health care access for plan members and Medicare beneficiaries. Rules, Regulations and legislative policies related to the Medicare Advantage program. Issues related to identifying and addressing social determinants of health and equity. Issues related to the insurance Marketplace and providing full and affordable coverage options. | CMS, House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Davita Inc. | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 Issues related to funding government departments and agencies responsible for administering programs that support Medicare Medicaid, Marketplace health care coverage for people living with ESRD. CMS Rules and Regulations focused on the promulgation of including certain oral medications in the ESRD bundle. Issues related to Medicare Advantage stars and other quality ratings. H.R. 6860 Restore Protections for Dialysis Patients Act of 2023 - Support for policies that allow people with ESRD and their families to more readily maintain their dialysis and health care coverage through their employers. Rules, regulations and guidance related to encouraging innovative models to support the health care of people with ESRD. Issues related to health care workforce shortages impacting the ability to support the care of people living with End Stage Renal Disease. Issues related to the treatment of necessary medications for dialysis patients., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 Issues related to funding government departments and agencies responsible for administering programs that support Medicare, Medicaid and Marketplace health care coverage for people with ESRD. Rules and Regulations focused on the inclusion of certain oral medications in the ESRD Medicare bundle. H.R. 6860 - Restore Protections for Dialysis Patients Act of 2023 - Support for policies that allow people with ESRD and their families to more readily maintain their dialysis and health care coverage through their employers. Support for CMS guidance encouraging innovative models to advance health care coverage for people living with ESRD. Issues related to health care workforce shortages impacting the ability to support the care of people living with End Stage Renal Disease. Issues related to the treatment of medications necessary for dialysis patients. | HHS, House of Representatives, Senate | 70,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Cambia Health Solutions (formerly Known As The Regence Group) | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Advantage and Part D programs. Issues related to Medicare Advantage stars and quality ratings. Issues related to the extension of the ACA APTC tax credits and the importance of their continuation for Americans insured through the Federal and State-Based Market Places. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable. H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces. HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules. Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces. Issues related to developing coherent prior authorization methodologies., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Advantage and Part D programs. Issues related to Medicare Advantage stars and other quality ratings. Issues related to the extension of the ACA APTC tax credits and the importance of their continuation for Americans insured through the Federal and State-Based Market Places. H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable. H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces. HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules, promulgation of the IRA and other issues impacting Medicare beneficiaries' ability to fully access their coverage. Issues related improving outcomes and access in mental and behavioral health in America. Issues related to developing coherent prior authorization methodologies. | House of Representatives, Senate | 80,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Community Catalyst | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support affordable accessible health care coverage. CMS Rules and Regulations focused on the promulgation of the EPSDT program. Administrative and Legislative issues regarding Medical Debt and protecting people from its implications. S. 3393 - The Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment Reauthorization Act. Issues related to ensuring access to substance use disorder and mental health treatment programs for families across the country. S. 2840 - Bipartisan Primary Care and Health Workforce Act - Issues related to ensuring that affordable, accessible healthcare services are available to all people equitably. Federal Rules, Regulations and Guidance related to essential health benefits as defined in the ACA and ensuring that they are upheld throughout the country. Issues related to fair promulgation and practices regarding the collection of medical debt. | House of Representatives, Senate | 20,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Pharmaceutical Care Management Association (pcma) | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues, Medicare/Medicaid, Pharmacy | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support prescription drug coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Part D program. S. 1542 - The DRUG Act - Issues related to ensuring that policies contemplated by Congress allow entities providing coverage of prescription medications have the tools they need to keep drugs affordable and accessible in the commercial market. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the underlying telemedicine extension, yet concern for the commercial delinking offset included in the legislation. S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare. S. 1339 - The Pharmacy Benefit Manager Reform Act - Issues focused on limiting spread pricing and requiring rebate pass through and other tools used to control the price of prescription medications. S. 127 - The PBM Transparency Act - Issues related to the study of Pharmacy Benefit Managers by the Federal Trade Commission. S. 150 - Affordable Prescriptions for Patients Act - Issues related to ensuring that people's access to affordable medications are not impeded and innovations to ensure fair pricing structures are promulgated to their fullest. Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States., H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support prescription drug coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Part D program. S. 1542 - The DRUG Act - Issues related to ensuring that policies contemplated by Congress allow entities providing coverage of prescription medications have the tools they need to keep drugs affordable and accessible in the commercial market. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the underlying telemedicine extension, yet concern for the commercial delinking offset included in the legislation. S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States. | House of Representatives, Senate | 70,000 | 4th Quarter - Report | 12/29/2024 |
| View Report | Ge Healthcare | No | Nathanson+hauck | Megan Hauck Marshall, Melanie Jan Nathanson | Health Issues | H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025 - Issues related to physician payment and access to critical medical technology. CMS Outpatient Prospective Payment (OPPS) Regulations - Issues related to ensuring better access to coverage of diagnostic tools for Americans with neurological disorders, cancer and other diseases across the country. H.R. 1199 - Facilitating Innovative Nuclear Diagnostics Act (The FIND Act) - Issues related to ensuring access to diagnostic testing for neurological disorders, cancer and other diseases requiring PET scans for accurate diagnosis. H.R. 7024 - Tax Relief for American Families and Workers Act of 2024 - Issues related to the R&D tax credit and other tax treatments to support job creation and innovation. Regulations, guidance and other activity related to artificial intelligence and health care. Regulations, guidance and other activity related to women's health care and research. Rules and regulations regarding the availability of diagnostic treatments and testing related to neurological disorders. Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel. Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease. Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs. Issues related to ensuring access to cancer screening and treatments. | CMS, HHS, House of Representatives, Senate | 60,000 | 4th Quarter - Report | 12/29/2024 |
| Who Lobbied? | Is the Client a Govt. Entity? | General Issues Lobbied On | Specific Issues Lobbied On | Govt. Agencies Lobbied | Dollar Amount Spent | Date Posted |
Learn about lobbying and how we sourced this data.
The data in this table is sourced directly from the Senate Office of Public Records on a daily basis and displays approximately 7 days of lobbying data at all times.
This table depicts just a subset of our alternative data offering and does not include long-term historical data, stock ticker mappings, lobbyist employment history, and client foreign entity and affiliated organizations information.
The Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.SENATE.GOV.
The Lobbying Disclosure Act (LDA) requires federal lobbyists to register with the Clerk of the House of Representatives and the Secretary of the Senate. The LDA stipulates that all active registrants file quarterly activity reports incorporating relevant information such as revenue generated from lobbying clients, specific issues on which they lobby, federal agencies contacted, and more in order to maintain some level of transparency in lobbying activity.
Source:Â Clerk of the U.S. House of Representatives and Secretary of the Senate
The first and only publicly accessible lobbying data dashboard, updated once every 24 hours, and with powerful searching and filtering abilities. (Data showcased is a subset of our alternative data).
Contact us directly to gain access to our entire database and dataset offerings. You can also find us on Eagle Alpha, Datarade, Neudata, Factset, and the AWS Data Exchange.
Get in touch for a quote, trials, & more.
Get in touch to learn more about our lobbying database, request data samples, and start a trial.